Cargando…
Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls
BACKGROUND: Metformin, a medication for type 2 diabetes, has been linked to many non-diabetes health benefits including increasing healthy lifespan. Previous work has only examined the benefits of metformin over periods of less than ten years, which may not be long enough to capture the true effect...
Autores principales: | Stevenson-Hoare, Joshua, Leonenko, Ganna, Escott-Price, Valentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155360/ https://www.ncbi.nlm.nih.gov/pubmed/37131166 http://dx.doi.org/10.1186/s12889-023-15764-y |
Ejemplares similares
-
Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
por: Leonenko, Ganna, et al.
Publicado: (2021) -
Polygenic risk and pleiotropy in neurodegenerative diseases
por: Bellou, Eftychia, et al.
Publicado: (2020) -
Are Alzheimer's and coronary artery diseases genetically related to longevity?
por: Bellou, Eftychia, et al.
Publicado: (2023) -
Defining functional variants associated with Alzheimer’s disease in the induced immune response
por: Harwood, Janet C, et al.
Publicado: (2021) -
Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)